We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+10.36%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.05B
AUM Growth
-$2.89B
Cap. Flow
-$2.96B
Cap. Flow %
-281.28%
Top 10 Hldgs %
16.51%
Holding
1,419
New
160
Increased
195
Reduced
212
Closed
815

Top Buys

Rank Stock Value
1
BAX icon
Baxter International
BAX
+$19.4M
2
BRCM
BROADCOM CORP CL-A
BRCM
+$19.4M
3
MON
Monsanto Co
MON
+$17.8M
4
ECL icon
Ecolab
ECL
+$17.1M
5
VC icon
Visteon
VC
+$13M

Top Sells

Rank Stock Value
1
YHOO
Yahoo Inc
YHOO
+$69.1M
2
GILD icon
Gilead Sciences
GILD
+$59.1M
3
MRK icon
Merck
MRK
+$54.1M
4
WFC icon
Wells Fargo
WFC
+$53.8M
5
X
US Steel
X
+$52.6M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.13%
2 Technology 13.74%
3 Healthcare 12.34%
4 Financials 12.02%
5 Industrials 7.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PHH
251
DELISTED
PHH Corporation
PHH
$1.03M 0.1%
42,948
-29,160
-40% -$678K
CUZ icon
252
Cousins Properties
CUZ
$5.29B
$1.03M 0.1%
+31,841
New +$1.09M
M icon
253
Macy's
M
$6.15B
$1.03M 0.1%
15,600
SNV
254
DELISTED
Synovus
SNV
$1.03M 0.1%
37,876
-66,424
-64% -$1.68M
ALKS icon
255
Alkermes
ALKS
$8.82B
$1.02M 0.1%
17,500
-21,901
-56% -$1.12M
LM
256
DELISTED
Legg Mason, Inc.
LM
$1.02M 0.1%
19,200
-115,927
-86% -$6.12M
LRCX icon
257
Lam Research
LRCX
$382B
$1.02M 0.1%
129,000
DYN
258
DELISTED
Dynegy, Inc.
DYN
$1.02M 0.1%
33,700
-20,120
-37% -$621K
APH icon
259
Amphenol
APH
$188B
$1.02M 0.1%
76,000
-21,832
-22% -$279K
CTB
260
DELISTED
Cooper Tire & Rubber Co.
CTB
$1.02M 0.1%
+29,500
New +$928K
VLO icon
261
Valero Energy
VLO
$89.8B
$1.02M 0.1%
20,600
-573,636
-97% -$27.8M
UVE icon
262
Universal Insurance Holdings
UVE
$1.16B
$1.02M 0.1%
49,792
+9,900
+25% +$173K
RKT
263
DELISTED
ROCK-TENN COMPANY CL-A
RKT
$1.02M 0.1%
16,700
-1,500
-8% -$81.4K
CHH icon
264
Choice Hotels
CHH
$5.03B
$1.02M 0.1%
18,142
-2,544
-12% -$137K
TTPH
265
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$1.02M 0.1%
+1,280
New +$689K
ADTN icon
266
Adtran
ADTN
$798M
$1.01M 0.1%
46,387
-11,015
-19% -$226K
HES
267
DELISTED
Hess
HES
$1.01M 0.1%
13,700
-84,821
-86% -$6.72M
SOHU
268
Sohu.com
SOHU
$336M
$1.01M 0.1%
19,000
+2,800
+17% +$135K
LYB icon
269
LyondellBasell Industries
LYB
$19.5B
$1.01M 0.1%
12,714
-251,549
-95% -$21.8M
AKRX
270
DELISTED
Akorn Inc
AKRX
$1.01M 0.1%
27,825
+1,200
+5% +$46.3K
DXPE icon
271
DXP Enterprises
DXPE
$2.62B
$1.01M 0.1%
19,908
+8,608
+76% +$516K
ISRG icon
272
Intuitive Surgical
ISRG
$121B
$1M 0.1%
17,100
CNH
273
CNH Industrial
CNH
$13.8B
$1M 0.1%
+142,039
New +$986K
FXI icon
274
iShares China Large-Cap ETF
FXI
$4.31B
$999K 0.09%
+24,000
New +$948K
X
275
DELISTED
US Steel
X
$995K 0.09%
37,200
-1,577,935
-98% -$52.6M

Similar funds

PDT Partners's Q4 2014 Portfolio in Review

As of Q4 2014, PDT Partners held 1,419 positions worth $1.05B, down 73% from $3.94B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

PDT Partners withdrew a net $2.96B in Q4 2014, closing 815 positions and reducing 212 holdings. Its most notable exit was Gilead Sciences, an estimated $59.1M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 13% a quarter earlier, followed by Technology and Healthcare.

Against the trend, PDT Partners opened a new position in Baxter International worth $19.8M.

  • PDT Partners's largest Q4 2014 buy was Baxter International: 498,449 shares worth $19.8M.
  • PDT Partners added most to Visteon in Q4 2014, an estimated $13M increase.
  • PDT Partners's biggest Q4 2014 reduction was Yahoo Inc, cutting an estimated $69.1M.
  • PDT Partners fully exited Gilead Sciences in Q4 2014, selling an estimated $59.1M.
  • PDT Partners's ten largest holdings make up 17% of its $1.05B portfolio in Q4 2014.
  • PDT Partners opened 160 new positions and closed 815 in Q4 2014.
  • PDT Partners's portfolio value fell 73% quarter-over-quarter to $1.05B.

Based on PDT Partners's 13F filing for Q4 2014, filed 17 Feb 2015.